Literature DB >> 8247034

Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation.

J E Fitzgibbon1, S Gaur, L D Frenkel, F Laraque, B R Edlin, D T Dubin.   

Abstract

BACKGROUND AND METHODS. We describe a child who apparently acquired human immunodeficiency virus type 1 (HIV-1) infection in the home setting. The suspected source of infection was a child with the acquired immunodeficiency syndrome who had received zidovudine and whose virus contained a mutation associated with in vitro zidovudine resistance. The children were born to different HIV-1-infected mothers, but they lived in the same home between the ages of two and five years. Child 1 was infected perinatally; Child 2 was not and was repeatedly found to be seronegative. Child 2 was examined because of acute lymphadenopathy and had seroconverted to HIV-1 positivity. HIV-1 proviral DNA was amplified from peripheral-blood mononuclear cells and subjected to sequence analysis. Sequences from Child 2 were compared with those from Child 2's mother, Child 1, and local HIV-1-infected control children.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8247034     DOI: 10.1056/NEJM199312163292502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  10 in total

1.  A review of selected blood-borne pathogen position statements and federal regulations.

Authors:  B L Arnold
Journal:  J Athl Train       Date:  1995-06       Impact factor: 2.860

2.  Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.

Authors:  K K Van Rompay; M D Miller; M L Marthas; N A Margot; P J Dailey; D R Canfield; R P Tarara; J M Cherrington; N L Aguirre; N Bischofberger; N C Pedersen
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  L-2-oxothiazolidine-4-carboxylic acid inhibits human immunodeficiency virus type 1 replication in mononuclear phagocytes and lymphocytes.

Authors:  W Z Ho; S E Starr; A Sison; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

Review 4.  Pediatric human immunodeficiency virus infection.

Authors:  J B Domachowske
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

5.  Public health interventions to reduce pediatric AIDS.

Authors:  J J Goedert; T R Coté
Journal:  Am J Public Health       Date:  1994-07       Impact factor: 9.308

6.  Policies of containment: immigration in the era of AIDS.

Authors:  A L Fairchild; E A Tynan
Journal:  Am J Public Health       Date:  1994-12       Impact factor: 9.308

7.  Genetically related human immunodeficiency virus type 1 in three adults of a family with no identified risk factor for intrafamilial transmission.

Authors:  L Bélec; A Si Mohamed; M C Müller-Trutwin; J Gilquin; L Gutmann; M Safar; F Barré-Sinoussi; M D Kazatchkine
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  A bite in the playroom: Managing human bites in child care settings.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

9.  Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs.

Authors:  Richard Pilon; Lynne Leonard; John Kim; Dominic Vallee; Emily De Rubeis; Ann M Jolly; John Wylie; Linda Pelude; Paul Sandstrom
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

10.  Human immunodeficiency virus transmission from a 24-year-old woman to her 78-year-old grandmother: a case report.

Authors:  Pedro Pallangyo; Jalack Millinga; Happy Swai; Naairah R Hemed; Zabela Mkojera; Silvia Mosha; Marcelina Granima; Smita Bhalia; Yona Gandye; Mohamed Janabi
Journal:  J Med Case Rep       Date:  2021-07-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.